Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma

Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) stands as one of the most prevalent malignancies. While PD-1 immune checkpoint inhibitors have demonstrated promising therapeutic efficacy in HCC, not all patients exhibit a favorable response to these treatments. Glutamine is a crucial immune cell regulatory factor, a...

Full description

Bibliographic Details
Main Authors: Guixiong Zhang, Yitai Xiao, Hang Liu, Yanqin Wu, Miao Xue, Jiaping Li
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Immunobiology
Subjects:
Hepatocellular carcinoma
Glutamine metabolism
Machine learning
SLC1A5
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S0171298524000597

Internet

http://www.sciencedirect.com/science/article/pii/S0171298524000597

Similar Items